pharmaceuticals
Save Big: Novo Nordisk Slashes Ozempic Prices for Cash-Paying U.S. Diabetes Patients
Novo Nordisk recently announced a significant price drop for Ozempic, their diabetes treatment. This move reflects growing pressure on drugmakers ... Read more
Novo Nordisk’s Wegovy: Breakthrough Obesity Drug Now Approved for Treating MASH
Novo Nordisk’s drug, Wegovy, recently received approval from U.S. regulators to treat a common liver disease called metabolic dysfunction-associated steatohepatitis ... Read more
Could the FDA Pull Pfizer’s COVID-19 Vaccine for Healthy Kids? What Parents Need to Know
The FDA might soon revoke authorization for Pfizer’s COVID-19 vaccine for healthy kids aged 6 months to 5 years. This ... Read more
“Breaking News: Pfizer’s COVID Vaccine for Kids Under 5 Faces Potential FDA Authorization Withdrawal”
The FDA is considering revoking its approval for Pfizer’s COVID-19 vaccine for healthy kids under 5. This decision, if finalized, ... Read more
Eli Lilly Boosts 2025 Forecast with Soaring Mounjaro and Zepbound Sales: Quarterly Results Exceed Expectations!
Eli Lilly recently announced impressive second-quarter results, surpassing expectations mainly due to strong sales of its weight loss and diabetes ... Read more
Eli Lilly’s Breakthrough Obesity Pill Achieves 12% Weight Loss in Key Late-Stage Trial: A Game Changer for Weight Management
Eli Lilly recently shared exciting news about its new weight loss pill. In a late-stage trial, the highest dose helped ... Read more
Trump Warns: Pharma Tariffs Could Soar to 250%—What This Means for You
President Donald Trump recently discussed potential tariffs on imported pharmaceuticals during an interview with CNBC. He mentioned that these tariffs ... Read more
Pfizer Boosts 2025 Profit Forecast: Discover How Cost Cuts and Stellar Quarterly Results Drive Growth
Pfizer recently raised its profit outlook for the year, pointing to strong performance and successful cost-cutting measures. The company now ... Read more
Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more
Breaking News: Vinay Prasad Leaves the FDA—What This Means for Public Health
Vinay Prasad, a key figure at the Food and Drug Administration (FDA), recently left his position amidst some heated discussions ... Read more
